Online Program Home
My Program

Abstract Details

Activity Number: 500
Type: Contributed
Date/Time: Wednesday, August 3, 2016 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract #319594 View Presentation
Title: Adaptive Enrichment with Subpopulation Selection at Interim
Author(s): Xiang Ling* and Sue-Jane Wang and Kun Jin and Hsien-Ming James Hung
Companies: FDA/CDER and FDA and FDA/CDER and FDA
Keywords: adaptive design ; enrichment ; sample size re-estimation
Abstract:

There seems to be growing interest in patient subpopulation enrichment whether pursued at study baseline or in an ongoing clinical trial for its potential to achieve the goal of personalized medicine. Adaptive enrichment has been proposed in multiple disease areas in drug development programs. According to the FDA draft guidance on enrichment strategies for drugs and biologics, in principle, enrichment can help to reduce patient heterogeneity, select a high risk patient subset or identify a subgroup of patients who are more likely to respond to treatment. In this presentation, we give a brief overview on adaptive enrichment and the methodologies that are growing in statistical literature. An approved neurologic drug development case example, which was planned to adapt two design elements, i.e., patient population adaptation and statistical information adaptation, will be shared. We will articulate the challenges in the implementation of a confirmatory adaptive enrichment trial and what population the treatment effect applies. We will also assess the consistency of treatment effect before and after statistical information adaptation.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association